Penumbra, Inc.
(NYSE : PEN)

( )
PEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.18%143.210.7%$521.63m
MDTMedtronic Plc
-1.15%110.500.6%$444.67m
ABTAbbott Laboratories
-0.29%83.650.8%$391.98m
TMOThermo Fisher Scientific, Inc.
-0.60%305.481.0%$391.67m
BDXBecton, Dickinson & Co.
0.90%249.001.1%$348.88m
SYKStryker Corp.
-1.50%201.241.3%$341.49m
BAXBaxter International, Inc.
0.29%82.241.8%$329.38m
ISRGIntuitive Surgical, Inc.
-0.12%571.822.4%$298.25m
DXCMDexCom, Inc.
-1.14%218.818.3%$285.76m
BSXBoston Scientific Corp.
-0.61%42.351.1%$280.60m
EWEdwards Lifesciences Corp.
-0.55%242.891.2%$280.03m
WMGIWright Medical Group NV
-0.07%29.498.3%$268.26m
ALGNAlign Technology, Inc.
1.25%272.146.4%$247.68m
ABMDABIOMED, Inc.
0.76%186.663.3%$171.60m
PODDInsulet Corp.
-2.47%175.786.7%$152.93m

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.